Suppr超能文献

滤泡性淋巴瘤的免疫组织架构模式:HGAL 和 LMO2 在检测滤泡间和弥漫成分中的效果。

Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.

机构信息

Department of Pathology, Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Am J Surg Pathol. 2010 Sep;34(9):1266-76. doi: 10.1097/PAS.0b013e3181e9343d.

Abstract

Follicular lymphoma (FL) can exhibit variant histologic patterns that can lead to confusion with other B-cell lymphomas and reactive conditions. Diagnostic markers such as CD10 and BCL2 may be difficult to interpret in variant FL patterns, and are often diminished or absent in the interfollicular and diffuse components. We evaluated 2 recently characterized germinal center B-cell markers, human germinal center associated lymphoma (HGAL), and LIM-only transcription factor 2 (LMO2), in 127 FL patient biopsies (94 nodal, 33 extranodal), and correlated the findings with histologic pattern, cellular composition, grade, and additional immunostains (CD20, CD3, CD21, CD10, BCL2, and BCL6). Architectural patterns included predominantly follicular (75%) and follicular and diffuse components (25%); 10 cases showed marginal zone differentiation and 3 were floral variants. Eighty-nine cases were low grade (38 grade 1; 51 grade 2) and 38 were grade 3 (29 grade 3A and 9 grade 3B). HGAL had the highest overall sensitivity of detecting FL and was superior in detecting the interfollicular and diffuse components compared with BCL2, LMO2, CD10, and BCL6. All 28 cases that lacked CD10, expressed HGAL, and the majority also expressed LMO2. Our results show that HGAL and LMO2 are sensitive markers for FL diagnosis. The addition of HGAL and LMO2 to the immunohistologic panel is beneficial in the work-up of nodal and extranodal B-cell lymphomas and the efficacy of HGAL in detecting the follicular, interfollicular and diffuse components of FL is of particular value in the setting of variant immunoarchitectural patterns.

摘要

滤泡性淋巴瘤(FL)可表现出多种组织学形态,这可能导致其与其他 B 细胞淋巴瘤和反应性疾病相混淆。在变异型 FL 中,CD10 和 BCL2 等诊断标志物可能难以解读,并且在滤泡间和弥漫性成分中通常减弱或缺失。我们评估了最近鉴定的 2 种生发中心 B 细胞标志物,人生发中心相关淋巴瘤(HGAL)和 LIM 仅转录因子 2(LMO2),在 127 例 FL 患者活检标本(94 例淋巴结,33 例结外)中,将这些发现与组织学形态、细胞组成、分级和其他免疫组化(CD20、CD3、CD21、CD10、BCL2 和 BCL6)相关联。结构模式包括主要滤泡性(75%)和滤泡性和弥漫性成分(25%);10 例显示边缘区分化,3 例为花形变异型。89 例为低级别(38 例 1 级;51 例 2 级),38 例为 3 级(29 例 3A 级和 9 例 3B 级)。HGAL 检测 FL 的总体敏感性最高,与 BCL2、LMO2、CD10 和 BCL6 相比,在检测滤泡间和弥漫性成分方面更具优势。所有 28 例缺乏 CD10、表达 HGAL 的病例,大多数也表达 LMO2。我们的结果表明,HGAL 和 LMO2 是 FL 诊断的敏感标志物。在对结内和结外 B 细胞淋巴瘤的免疫组化分析中添加 HGAL 和 LMO2 是有益的,在变异型免疫组织学形态的情况下,HGAL 在检测 FL 的滤泡、滤泡间和弥漫性成分方面的功效具有特别的价值。

相似文献

3
[Expression and significance of HGAL and LMO2 in follicular lymphoma].HGAL和LMO2在滤泡性淋巴瘤中的表达及意义
Zhonghua Bing Li Xue Za Zhi. 2016 Feb;45(2):83-5. doi: 10.3760/cma.j.issn.0529-5807.2016.02.003.

引用本文的文献

2
Managing Follicular Lymphoma in the Elderly Population.老年人群滤泡性淋巴瘤的管理
Case Rep Med. 2023 Jan 5;2023:1038934. doi: 10.1155/2023/1038934. eCollection 2023.
4
The broad landscape of follicular lymphoma: Part I.滤泡性淋巴瘤的广泛概况:第一部分。
Pathologica. 2020 Mar;112(1):1-16. doi: 10.32074/1591-951X-35-19. Epub 2020 Jan 22.
10
Smad1 expression in follicular lymphoma.滤泡性淋巴瘤中的Smad1表达
J Pathol Transl Med. 2015 May;49(3):243-8. doi: 10.4132/jptm.2015.03.30. Epub 2015 May 15.

本文引用的文献

1
BCL6, MUM1, and CD10 expression in mantle cell lymphoma.套细胞淋巴瘤中BCL6、MUM1和CD10的表达情况
Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):103-8. doi: 10.1097/PAI.0b013e3181bb9edf.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验